Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease

Trends in Endocrinology and Metabolism

Volumn 10, Issue 9, 1999, Pages 359-368

  Elenkov, Ilia J ^a,b   Chrousos, George P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GLUCOCORTICOID; HISTAMINE;

CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE PREDISPOSITION; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATION; MAST CELL; PRIORITY JOURNAL; REVIEW; STRESS;

EID: 0033231334     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(99)00188-5     Document Type: Review

References (64)

1. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New Engl. J. Med. 332:1995;1351-1362.
2. Besedovsky H.O., Del Rey A., Sorkin E., Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 233:1986;652-654.
3. Kovacs K.J., Elenkov I.J. Differential dependence of ACTH secretion induced by various cytokines on the integrity of the paraventricular nucleus. J. Neuroendocrinol. 7:1995;15-23.
4. Akita S., Conn P.M., Melmed S. Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function. J. Clin. Endocrinol. Metab. 81:1996;4170-4178.
5. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-53.
6. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
7. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
8. Elenkov I.J., Papanicolaou D.A., Wilder R.L., Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Amer. Physic. 108:1996;374-381.
9. + lymphocytes. J. Immunol. 158:1997;5589-5595.
10. + lymphocytes by inhibiting IL-12 production. J. Immunol. 160:1998;2231-2237.
11. Wu C.Y., Wang K., McDyer J.F., Seder R.A. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161:1998;2723-2730.
12. van der Poll T., Barber A.E., Coyle S.M., Lowry S.F. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia - a clinical research center study. J. Clin. Endocrinol. Metab. 81:1996;3604-3606.
13. + T cells in vitro. J. Immunol. 156:1996;2406-2412.
14. Tabardel Y.et al. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery. 119:1996;76-80.
15. Gayo A., Mozo L., Suarez A., Tunon A., Lahoz C., Gutierrez C. Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse. J. Neuroimmunol. 85:1998;122-130.
16. Panina-Bordignon Pet al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100:1997;1513-1519.
17. Hasko G., Szabo C., Nemeth Z.H., Salzman A.L., Vizi E.S. Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J. Neuroimmunol. 88:1998;57-61.
18. Sanders V.M., Baker R.A., Ramer-Quinn D.S., Kasprowicz D.J., Fuchs B.A., Street N.E. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J. Immunol. 158:1997;4200-4210.
19. Borger Pet al. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am. J. Respir. Cell. Mol. Biol. 19:1998;400-407.
20. Hasko G., Elenkov I.J., Kvetan V., Vizi E.S. Differential effect of selective block of alpha 2-adrenoreceptors on plasma levels of tumour necrosis factor-alpha, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. J. Endocrinol. 144:1995;457-462.
21. Elenkov I.J., Hasko G., Kovacs K.J., Vizi E.S. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J. Neuroimmunol. 61:1995;123-131.
22. Woiciechowsky Cet al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 4:1998;808-813.
23. Whalen M.M., Bankhurst A.D. Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochem. J. 272:1990;327-331.
24. Hellstrand K., Hermodsson S. An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int. Arch. Allergy Appl. Immunol. 89:1989;334-341.
25. Irwin M. Stress-induced immune suppression: role of brain corticotropin releasing hormone and autonomic nervous system mechanisms. Adv. Neuroimmunol. 4:1994;29-47.
26. Batuman O.A., Ferrero A., Cupp C., Jimenez S.A., Khalili K. Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells. J. Immunol. 155:1995;4397-4405.
27. Spengler R.N., Allen R.M., Remick D.G., Strieter R.M., Kunkel S.L. Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 145:1990;1430-1434.
28. Le Tulzo Yet al. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression. J. Clin. Invest. 99:1997;1516-1524.
29. Baker A.J., Fuller R.W. Loss of response to beta-adrenoceptor agonists during the maturation of human monocytes to macrophages in vitro. J. Leukocyte Biol. 57:1995;395-400.
30. Linden A. Increased interleukin-8 release by beta-adrenoceptor activation in human transformed bronchial epithelial cells. Br. J. Pharmacol. 119:1996;402-406.
31. Karalis K., Sano H., Redwine J., Listwak S., Wilder R.L., Chrousos G.P. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 254:1991;421-423.
32. Webster E.L., Torpy D.J., Elenkov I.J., Chrousos G.P. Corticotropin-releasing hormone and inflammation. Ann. New York Acad. Sci. 840:1998;21-32.
33. Theoharides T.Cet al. Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology. 136:1995;5745-5750.
34. Udelsman R., Gallucci W.T., Bacher J., Loriaux D.L., Chrousos G.P. Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey. Peptides. 7:1986;465-471.
35. Theoharides T.Cet al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology. 139:1998;403-413.
36. Bamberger C.M., Wald M., Bamberger A.M., Ergun S., Beil F.U., Schulte H.M. Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J. Clin. Endocrinol. Metab. 83:1998;708-711.
37. Schwartz S.A., Nair M.P.N. Histamine in the immunoregulation of cellular cytotoxicity. Rocklin R.E. Histamine and H2 Antagonists in Inflammation and Immunodeficiency. 1990;65-79 Marcel Dekker.
38. Elenkov I.J., Webster E., Papanicolaou D.A., Fleisher T.A., Chrousos G.P., Wilder R.L. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol. 161:1998;2586-2593.
39. Lagier B., Lebel B., Bousquet J., Pene J. Different modulation by histamine of IL-4 and interferon-gamma (IFN-gamma) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin. Exp. Immunol. 108:1997;545-551.
40. Altare Fet al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science. 280:1998;1432-1435.
41. Lerner B.H. Can stress cause disease? Revisiting the tuberculosis research of Thomas Holmes, 1949-1961. Ann. Intern. Med. 124:1996;673-680.
42. Elenkov I.J., Vizi E.S. Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen. Neuropharmacology. 30:1991;1319-1324.
43. Vizi E.S., Orso E., Osipenko O.N., Hasko G., Elenkov I.J. Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience. 68:1995;1263-1276.
44. Cole S.W., Korin Y.D., Fahey J.L., Zack J.A. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J. Immunol. 161:1998;610-616.
45. Haraguchi S., Good R.A., James-Yarish M., Cianciolo G.J., Day N.K. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections. Proc. Natl. Acad. Sci. U. S. A. 92:1995;5568-5571.
46. Clerici M., Bevilacqua M., Vago T., Villa M.L., Shearer G.M., Norbiato G. An immunoendocrinological hypothesis of HIV infection. Lancet. 343:1994;1552-1553.
47. Kino T., Gragerov A., Kopp J.B., Stauber R.H., Pavlakis G.N., Chrousos G.P. The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J. Exp. Med. 189:1999;51-62.
48. Cohen S., Tyrrell D.A., Smith A.P. Psychological stress and susceptibility to the common cold. New Engl. J. Med. 325:1991;606-612.
49. O'Sullivan S.T., Lederer J.A., Horgan A.F., Chin D.H., Mannick J.A., Rodrick M.L. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222:1995;482-490.
50. Segal B.M., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:1998;537-546.
51. Rogers M.P., Fozdar M. Psychoneuroimmunology of autoimmune disorders. Adv. Neuroimmunol. 6:1996;169-177.
52. Wilder R.L. Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 13:1995;307-338.
53. Elenkov I.J., Hoffman J., Wilder R.L. Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol. Med. Today ;3. 379-383:1997.
54. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4:1998;781-785.
55. Takahashi Yet al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8227-8232.
56. Barnes P., FitzGerald G., Brown M., Dollery C. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. New Engl. J. Med. 303:1980;263-267.
57. Zieg G., Lack G., Harbeck R.J., Gelfand E.W., Leung D.Y. In vivo effects of glucocorticoids on IgE production. J. Allergy Clin. Immunol. 94:1994;222-230.
58. Coqueret O., Lagente V., Frere C.P., Braquet P., Mencia-Huerta J.M. Regulation of IgE production by beta 2-adrenoceptor agonists. Ann. New York Acad. Sci. 725:1994;44-49.
59. Colombo M.Pet al. Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res. 56:1996;2531-2534.
60. Chouaib S., Asselin-Paturel C., Mami-Chouaib F., Caignard A., Blay J.Y. The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol. Today. 18:1997;493-497.
61. Shakhar G., Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J. Immunol. 160:1998;3251-3258.
62. + T cells. Anticancer Res. 17:1997;4259-4268.
63. Matsumoto S. Cimetidine and survival with colorectal cancer. Lancet. 346:1995;115.
64. Pacak K., Palkovits M., Yadid G., Kvetnansky R., Kopin I.J., Goldstein D.S. Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. Am. J. Physiol. 275:1998;R1247-R1255.